Statistical challenges and opportunities in drug development – the Boehringer-Ingelheim perspective
主 题: Statistical challenges and opportunities in drug development – the Boehringer-Ingelheim perspective
报告人: Hans-Juergen Lomp (Boehringer Ingelheim)
时 间: 2016-06-17 14:00 - 15:00
地 点: 理科一号楼1114
The application of statistics within medical science is regarded as one of the great medical breakthroughs in the last millennium (New England Journal of Medicine, 2000, 342:42-49). Accordingly pharmaceutical companies are among the largest producers of medical statistics. Despite the long history of medical statistics within drug development there are still methodological challenges. This include for instance increased focus on more efficient clinical development processes and on patient tailored treatment (i.e. personalized medicine). In this talk I discuss how Boehringer-Ingelheim works with statistics and the methodological challenges the company sees as well as present the role of the statistician in a large pharmaceutical company.
